Rosetta Genomics Ltd. (Philadelphia), a developer of microRNA-based molecular diagnostics, and Super Religare Laboratories Limited (SRL; New Dehli), India’s largest diagnostics network, announced that they have signed an exclusive distribution agreement for Rosetta Genomics’ three currently-available diagnostic tests. Under the terms of the agreement, SRL will market Rosetta Genomics’ miRview tests in India, Saudi Arabia, Qatar, and the United Arab Emirates. Samples will be sent from SRL’s territories to Rosetta Genomics’ Philadelphia-based CLIA-certified laboratory for analysis. The terms of the deal were not disclosed. The two companies have also discussed the possibility to expand their relationship into research and development projects.
Tags: Collaboration, Emerging Markets
